首页 | 本学科首页   官方微博 | 高级检索  
检索        

肝脏特异性Nampt基因敲除对缺血性脑卒中的影响
引用本文:青胜利,王淑娜,汪东昇,吕小群,徐添颖,缪朝玉.肝脏特异性Nampt基因敲除对缺血性脑卒中的影响[J].药学实践杂志,2022,40(1):12-19.
作者姓名:青胜利  王淑娜  汪东昇  吕小群  徐添颖  缪朝玉
作者单位:海军军医大学药学系药理学教研室,上海 200433;海军军医大学麻醉系麻醉药理学教研室,上海 200433;复旦大学附属金山医院药剂科,上海 201508
基金项目:国家自然科学基金资助项目(81730098); 上海市科委动物专项(16140904500)
摘    要:目的 烟酰胺磷酸核糖转移酶(nicotinamide phosphoribosyltransferase,Nampt)是缺血性脑卒中的治疗新靶点.本研究旨在阐明肝脏来源的Nampt是否对缺血性脑卒中具有保护作用.方法 运用Cre/loxP系统制备肝脏特异性Nampt基因敲除小鼠.将NamptloxP/loxP小鼠与肝脏...

关 键 词:烟酰胺磷酸核糖转移酶  特异性敲除  肝脏  脑卒中
收稿时间:2021/7/22 0:00:00
修稿时间:2021/10/27 0:00:00

Effects of liver-specific Nampt knockout on ischemic stroke
QING Shengli,WANG Shun,WANG Dongsheng,LYU Xiaoqun,XU Tianying,MIAO Chaoyu.Effects of liver-specific Nampt knockout on ischemic stroke[J].The Journal of Pharmaceutical Practice,2022,40(1):12-19.
Authors:QING Shengli  WANG Shun  WANG Dongsheng  LYU Xiaoqun  XU Tianying  MIAO Chaoyu
Institution:Naval Medical University, Department of Pharmacology, School of Pharmacy, Shanghai 200433, China;Naval Medical University, Department of Anesthetic Pharmacology, Faculty of Anesthesiology, Shanghai 200433, China;Department of Pharmacy, Jinshan Hospital, Fudan University, Shanghai 201508, China
Abstract:Objective Nicotinamide phosphoribosyltransferase (Nampt) is a new therapeutic target for ischemic stroke. The aim of this study was to investigate protective effect of liver-derived Nampt on ischemic stroke. Methods Liver-specific Nampt knockout mice were generated using the Cre/loxP system. NamptloxP/loxP mice were crossed with liver-specific Cre recombinase expression mice (Alb-Cre), and the progeny genotypes were identified by polymerase chain reaction. Body weight of knockout mice and control mice were measured. Nampt in liver and brain was determined by Western blot assay. Middle cerebral artery occlusion (MCAO), a classical ischemic stroke model, was generated in liver-specific Nampt knockout mice and control mice by electrocoagulation. After 24 h of modeling, neurological deficit scores of each group were evaluated and TTC staining was performed to determine the cerebral infarction volume. The level of plasma Nampt in each group was determined by ELISA. Results Liver-specific Nampt knockout mice with the genotype of NamptloxP/loxPAlb-Cre were successfully constructed. The hepatic Nampt expression in knockout mice was significantly decreased by 74.2% compared to control mice, while there was no significant difference in the expression of brain Nampt protein between the knockout group and the control group. Specific knockout of liver Nampt gene expression had no effect on the body weight of mice. Under normal physiological conditions, there was no significant difference in plasma Nampt levels between liver-specific Nampt knockout mice and control mice of the same gender. 24 h after MCAO modeling, there were no significant differences in neurological deficit scores, cerebral infarct volume and plasma Nampt concentration between liver-specific Nampt knockout group and control group. Conclusion Liver-specific Nampt knockout mice are successfully constructed. Liver-derived Nampt has no significant protective effects on ischemic stroke.
Keywords:Nampt  specific knockout  liver  stroke
本文献已被 维普 等数据库收录!
点击此处可从《药学实践杂志》浏览原始摘要信息
点击此处可从《药学实践杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号